Dabur India Company History

History

:: Birth of Dabur

The birth of Dabur in a small Calcutta pharmacy, where Dr. S.K. Burman launches his mission of making health care products.

:: Setting up a manufacturing plant

With growing popularity of Dabur products, Dr. Burman expands his operations by setting up a manufacturing plant for mass production of formulations.

:: Ayurvedic medicines

Dabur enters the specialised area of nature-based Ayurvedic medicines, for which standardised drugs are not available in the market.

:: Establishment of research laboratories.

The need to develop scientific processes and quality checks for mass production of traditional Ayurvedic medicines leads to establishment of research laboratories.

:: Expands further

Dabur expands further with new manufacturing units at Narendrapur and Daburgram. The distribution of Dabur products spreads to other states like Bihar and the North-East.

:: Dabur India (Dr. S. K. Burman) Pvt. Ltd.

Dabur becomes a full-fledged company - Dabur India (Dr. S. K. Burman) Pvt. Ltd.

:: Shift to Delhi

Dabur's operations shift to Delhi. A new manufacturing plant is set up in temporary premises in Faridabad, on the outskirts of Delhi.

:: Sahibabad factory / Dabur Research & Development Centre (DRDC)

Commercial production starts in the new Sahibabad factory of Dabur, one of the largest and best equipped production facilities for Ayurvedic medicines. Launch of full-fledged research operations in pioneering areas of health care with establishment of the Dabur Research & Development Centre (DRDC).

:: Public Limited Company

Dabur becomes a Public Limited Company. Dabur India Ltd. comes into being after reverse merger with Vidogum Limited.

:: Joint venture with Agrolimen of Spain

Beginning a new chapter of strategic partnerships with international businesses, Dabur enters into a joint venture with Agrolimen of Spain. This new venture is to manufacture and market confectionery items in India.

:: Cancer treatment

Dabur enters the specialised health care area of cancer treatment with its oncology formulation plant at Baddi in Himachal Pradesh.

:: Public issue

Dabur India Ltd. raises its first public issue. Due to market confidence in the Company, shares issued at a high premium are oversubscribed 21 times.

:: Turnover of Rs.1,000 crores

Dabur establishes its market leadership status with a turnover of Rs.1,000 crores. From a small beginning and upholding the values of its founder, Dabur now enters the august league of large corporate businesses.

:: Professionals to manage the Company

With changing demands of business and to inculcate a spirit of corporate governance, the Burman family inducts professionals to manage the Company. For the first time in the history of Dabur, a non-family professional CEO sits at the helm of the Company.

:: Foods Division / Project STARS

Dabur enters full-scale in the nascent processed foods market with the creation of the Foods Division.
Project STARS (Strive to Achieve Record Successes) is initiated to give a jump-start to the Company and accelerate its growth performance.

:: 3 separate divisions

For better operation and management, 3 separate divisions created according to their product mix - Health Care Products Division, Family Products Division and Dabur Ayurvedic Specialties Limited.

:: Dabur demerges Pharma Business

Dabur India approved the demerger of its pharmaceuticals business from the FMCG business into a separate company as part of plans to provider greater focus to both the businesses. With this, Dabur India now largely comprises of the FMCG business that include personal care products, healthcare products and Ayurvedic Specialities, while the Pharmaceuticals business would include Allopathic, Oncology formulations and Bulk Drugs. Dabur Oncology Plc, a subsidiary of Dabur India, would also be part of the Pharmaceutical business.

:: Dabur acquires Balsara

As part of its inorganic growth strategy, Dabur India acquires Balsara's Hygiene and Home products businesses, a leading provider of Oral Care and Household Care products in the Indian market, in a Rs 143-crore all-cash deal.

::Dabur announces Bonus after 12 years

Dabur India announced issue of 1:1 Bonus share to the shareholders of the company, i.e. one share for every one share held. The Board also proposed an increase in the authorized share capital of the company from existing Rs 50 crore to Rs 125 crore.

::Dabur crosses $2 Bln market Cap, adopts US GAAP

Dabur India crosses the $2-billion mark in market capitalisation. The company also adopted US GAAP in line with its commitment to follow global best practices and adopt highest standards of transparency and governance.

::Approves FCCB/GDR/ADR up to $200 million

Moving forward on the inorganic growth path, Dabur India decides to raise up to $200 million from the international market through Bonds, FCCBs, GDR, ADR, QIPs or any other securities.The capital raised will be used to fund Dabur's aggressive growth ambitions and acquisition plans in India and abroad.

::Celebrating 10 years of Real

Dabur Foods unveiled the new packaging and design for Real at the completion of 10 years of the brand. The new refined modern look depicts the natural goodness of the juice from freshly plucked fruits.

::Foray into organised retail

Dabur India announced its foray into the organised retail business through a wholly-owned subsidiary, H&B Stores Ltd. Dabur will invest Rs 140 crores by 2010 to establish its presence in the retail market in India with a chain of stores on the Health & Beauty format.

::Dabur Foods Merged With Dabur India

Dabur India decides to merge its wholly-owned subsidiary Dabur Foods Limited with itself to extract synergies and unlock operational efficiencies. The integration will also help Dabur sharpen focus on the high growth business of foods and beverages, and enter newer product categories in this space.

:: Joint ventures

Extending its global partnerships, Dabur enters into joint ventures with Osem of Israel for food and Bongrain of France for cheese and other dairy products.

:: Acquires Fem Care Pharma

Dabur India acquires Fem Care Pharma, a leading player in the women's skin care market. Besides an entry into the high-growth skin care market with an established brand name FEM, this transaction also offers Dabur a strong platform to enter newer product categories and markets.

:: Dabur Red Toothpaste joins 'Billion Rupee Brand' club

Dabur Red Toothpaste becomes the Dabur's ninth Billion Rupee brand. Dabur Red Toothpaste crosses the billion rupee turnover mark within five years of its launch.

:: Dabur makes its first overseas acquisition

Dabur makes its first overseas acquisition, buying Hobi Kozmetik Kozmetik Group, a leading personal care products company in Turkey, for $69 million. This is followed in quick succession by the acquisition of 100% equity in Namasté Laboratories LLC of the US for $100 million.

:: Dabur enters professional skin care market

Dabur enters professional skin care market with the launch of OxyLife Professional Facial Kit, created exclusively for professional use. The range is further expanded with the launch of facials and a body bleach under the brand Fem.

:: Dabur India acquires 30-Plus from Ajanta Pharma

Dabur India Ltd acquired Ajanta Pharma’s over-the-counter energizer brand ’30-Plus’.

:: Dabur crosses Billion-Dollar Turnover Mark

Dabur India Ltd surpassed the Billion-Dollar Turnover mark during the 2011-12 fiscal to end the year with Net Sales of Rs 5,283.17 Crore.

1884		Birth of Dabur
1896		Setting up a manufacturing plant
Early 1900s		Ayurvedic medicines
1919		Establishment of research laboratories
1920		Expands further
1936		Dabur India (Dr. S.K. Burman) Pvt. Ltd.
1972		Shift to Delhi
1979		Sahibabad factory / Dabur Research & Development Centre (DRDC)
1986		Public Limited Company
1992		Joint venture with Agrolimen of Spain
1993		Cancer treatment
1994		Public issues
1995		Joint Ventures
1996		3 separate divisions
1997		Foods Division / Project STARS
1998		Professionals to manage the Company
2000		Turnover of Rs.1,000 crores
2003		Dabur demerges Pharma Business
2005		Dabur aquires Balsara
2005		Dabur announces Bonus after 12 years
2006		Dabur crosses $2 Bin market Cap, adopts US GAAP
2006		Approves FCCB/GDR/ADR up to $200 million
2007		Celebrating 10 years of Real
2007		Foray into organised retail
2007		Dabur Foods Merged With Dabur India
2008		Acquires Fem Care Pharma
2009		Dabur Red Toothpaste joins 'Billion Rupee Brand' club
2010		Dabur makes its first overseas acquisition
2011		Dabur enters professional skin care market
2011		Dabur India acquires 30-Plus from Ajanta Pharma
2012		Dabur crosses Billion-Dollar Turnover Mark

Sensex : 19245.70
Last : 156.50
High : 158.10
Low : 154.40
Last update : Jun 19,2013 3:46:00 PM

BSE Updates: